title: Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis.
authors: Agnieszka
authors: A
authors: Wojtkiewicz
authors: Mariusz
authors: M
authors: Wysocki
authors: Jacek
authors: J
authors: Fortuna
authors: Małgorzata
authors: M
authors: Chrupek
authors: Maciej
authors: M
authors: Matczuk
authors: Andrzej
authors: A
authors: Koltan
mesh_terms: D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000069285:Infliximab; D013262:Stevens-Johnson Syndrome / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab